Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Phase II Data May Be Good Sign For 8mg Aflibercept, But Will Payers Bite?
Feb 14 2022
•
By
Alaric DeArment
Regeneron announced Phase II data for aflibercept 8mg in wet AMD • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Sensory
More from Therapy Areas